sellWeak cluster of 610b5-1 plan
Alexandra Balcom sold $3.5M of NUVL
Chief Financial Officer at Nuvalent, Inc.. 40,000 shares at an average of $87.36, traded Oct 13, 2025, filed Oct 15, 2025.
Warning score
37Value
$3.5M
40,000 shares
Holdings after
61,734
-49% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +22RoleCFO
- +25Trade size$3.5M at market
- +10Share of holdings soldSold 49% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001193125-25-240314, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 13, 2025 | MOption exercise Class A Common Stock10b5-1 | +6,875 | $6.89 | $47k | 68,609 | Oct 15, 2025 |
| Oct 13, 2025 | MOption exercise Class A Common Stock10b5-1 | +13,125 | $18.93 | $248k | 81,734 | Oct 15, 2025 |
| Oct 13, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -6,138 | $87.90 | $540k | 75,596 | Oct 15, 2025 |
| Oct 13, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -12,266 | $88.73 | $1.1M | 63,330 | Oct 15, 2025 |
| Oct 13, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -1,596 | $89.22 | $142k | 61,734 | Oct 15, 2025 |
| Oct 14, 2025 | MOption exercise Class A Common Stock10b5-1 | +20,000 | $18.93 | $379k | 81,734 | Oct 15, 2025 |
| Oct 14, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -12,280 | $85.75 | $1.1M | 69,454 | Oct 15, 2025 |
| Oct 14, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -5,820 | $86.63 | $504k | 63,634 | Oct 15, 2025 |
| Oct 14, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -1,700 | $87.67 | $149k | 61,934 | Oct 15, 2025 |
| Oct 14, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -200 | $88.90 | $18k | 61,734 | Oct 15, 2025 |
| Oct 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,875 | $0.00 | $0 | 35,976 | Oct 15, 2025 |
| Oct 13, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -13,125 | $0.00 | $0 | 50,662 | Oct 15, 2025 |
| Oct 14, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 30,662 | Oct 15, 2025 |
Related signals
Other insiders at Nuvalent, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 14Weak | Nuvalent, Inc. | Deborah Ann Miller Chief Legal Officer | $543k 5,500 shares | -8% | |
| 32Weak | Nuvalent, Inc. | Alexandra Balcom Chief Financial Officer | $2.5M 25,130 shares | -23% | |
| 30Weak | Nuvalent, Inc. | Henry E. Pelish Chief Scientific Officer | $3.4M 35,104 shares | -35% | |
| 30Weak | Nuvalent, Inc. | James Richard Porter President and CEO | $3.0M 30,000 shares | -8% | |
| 14Weak | Nuvalent, Inc. | Deborah Ann Miller Chief Legal Officer | $567k 5,500 shares | -8% | |
| 14Weak | Nuvalent, Inc. | Darlene Noci Chief Development Officer | $567k 5,500 shares | -9% | |
| 7Weak | Nuvalent, Inc. | Darlene Noci Chief Development Officer | $561k 5,500 shares | -9% | |
| 18Weak | Nuvalent, Inc. | Deborah Ann Miller Chief Legal Officer | $1.7M 15,000 shares | -25% | |
| 38Weak | Nuvalent, Inc. | Alexandra Balcom Chief Financial Officer | $721k 7,417 shares | -8% | |
| 35Weak | Nuvalent, Inc. | Deborah Ann Miller Chief Legal Officer | $676k 6,952 shares | -14% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.